Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules

ClinicalTrials.gov ID: NCT04440176

Public ClinicalTrials.gov record NCT04440176. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2b, RANDOMIZED, OBSERVER-BLINDED TRIAL TO DESCRIBE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MenABCWY ADMINISTERED ON 2 DIFFERENT DOSING SCHEDULES IN HEALTHY PARTICIPANTS ≥11 TO <15 YEARS OF AGE

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to describe the short-term immunogenicity and safety of 2 doses of Neisseria meningitidis group A, B, C, W, and Y vaccine (MenABCWY) separated by either 12 or 36 months during adolescence, and immunopersistence up to 24 months after completing 2 doses separated by a 12-month interval.

Study identification

NCT ID
NCT04440176
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
309 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
11 Years to 14 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 17, 2020 (Actual)
Primary completion
Jan 5, 2024 (Actual)
Completion
Jan 5, 2024 (Actual)
Last update posted
Apr 27, 2026

2020 – 2024

United States locations

U.S. sites
20
U.S. states
9
U.S. cities
17
Facility City State ZIP Site status
AMR Clinical Mobile Alabama 36608 —
California Research Foundation San Diego California 92123 —
Nona Pediatric Center Orlando Florida 32829 —
Velocity Clinical Research, Norfolk Norfolk Nebraska 68701 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45206 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Ohio Pediatric Research Association Inc. Dayton Ohio 45414 —
Coastal Carolina Research Center North Charleston South Carolina 29405 —
Benchmark Research Fort Worth Texas 76135 —
Texas Health Resources Fort Worth Texas 76135 —
Diagnostics Research Group San Antonio Texas 78229 —
Wee Care Pediatrics Kaysville Utah 84037 —
Wasatch Pediatrics, Cottonwood Office Murray Utah 84107 —
Utah Valley Pediatrics - Timpanogos Office Orem Utah 84057 —
AMR Clinical Roy Utah 84067 —
J. Lewis Research, Inc. / Foothill Family Clinic Salt Lake City Utah 84109 —
J. Lewis Research, Inc. / Foothill Family Clinic South Salt Lake City Utah 84121 —
AMR Clinical South Jordan Utah 84095 —
Wee Care Pediatrics Syracuse Utah 84075 —
Pediatric Research of Charlottesville, LLC Charlottesville Virginia 22902 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04440176, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04440176 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →